Celgene Corporation
Records under this name other than the patents Celgene Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 291 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,427,638 | (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione:, and Methods of Synthesis and Compositions Thereof now held by Amgen Inc. In force · High confidence | In force | High confidence | |
| US 8,609,679 | 2,4-Diaminopyrimidines Useful as Kinase Inhibitors now held by Bristol-Myers Squibb Company In force · High confidence | In force | High confidence | |
| US 8,710,222 | 2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors now held by Bristol-Myers Squibb Company In force · High confidence | In force | High confidence | |
| US 9,212,181 | Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors now held by Bristol-Myers Squibb Company In force · High confidence | In force | High confidence | |
| US 9,296,737 | Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors now held by Bristol-Myers Squibb Company In force · High confidence | In force | High confidence | |
| US 9,987,276 | Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors now held by Bristol-Myers Squibb Company In force · High confidence | In force | High confidence | |
| US 10,010,548 | 2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors now held by Bristol-Myers Squibb Company In force · High confidence | In force | High confidence | |
| US 10,596,172 | 2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors now held by Bristol-Myers Squibb Company In force · High confidence | In force | High confidence | |
| US 10,828,300 | Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors now held by Bristol-Myers Squibb Company In force · High confidence | In force | High confidence | |
| US 11,351,168 | 2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors now held by Bristol-Myers Squibb Company In force · High confidence | In force | High confidence |